Azaindole derivative

Details for Australian Patent Application No. 2009306795 (hide)

Owner Merck Patent GmbH

Inventors Heinrich, Timo; Koolman, Hannes

Agent Davies Collison Cave

Pub. Number AU-A-2009306795

PCT Pub. Number WO2010/046013

Priority 10 2008 052 943.5 23.10.08 DE

Filing date 24 September 2009

Wipo publication date 29 April 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/404 (2006.01)

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/10 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/046013 Priority application(s): WO2010/046013

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009306819-Isoquinolinone derivatives as NK3 antagonists

2009306788-Linear guide for the falling weight of a pile hammer